1192372-11-4 Usage
General Description
Methyl 4-chloro-1H-imidazole-5-carboxylate is a chemical compound used in the pharmaceutical industry as an intermediate for the synthesis of various pharmaceuticals and agrochemicals. It is a white to off-white powder with a molecular formula of C6H6ClN3O2 and a molecular weight of 197.58 g/mol. Methyl 4-chloro-1H-iMidazole-5-carboxylate is commonly used in the development of antifungal and antibacterial drugs. It is also used as a building block in the preparation of synthetic organic compounds for various research and development purposes. Methyl 4-chloro-1H-imidazole-5-carboxylate is an important chemical in the production of medicines and other biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1192372-11-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,2,3,7 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1192372-11:
(9*1)+(8*1)+(7*9)+(6*2)+(5*3)+(4*7)+(3*2)+(2*1)+(1*1)=144
144 % 10 = 4
So 1192372-11-4 is a valid CAS Registry Number.
1192372-11-4Relevant articles and documents
NOVEL INDAZOLE COMPOUND OR SALT THEREOF
-
Paragraph 0255, (2021/09/02)
An indazole compound represented by the following Formula (I) or a salt thereof: wherein X, R1, R2, ring A, L1, L2, L3, and R5 are as defined in this specification.
KRAS G12D PROTEIN INHIBITORS
-
Paragraph 00121, (2021/10/30)
Compounds and pharmaceutically acceptable salts thereof inhibit the G12D mutant of KRAS protein and are expected to have utility as therapeutic agents, for example, for the treatment of cancer.
CHEMICAL COMPOUNDS
-
Page/Page column 146, (2009/01/24)
The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.
